Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elobixibat plus sodium picosulfate with magnesium citrate vs 2-L PEG with ascorbic acid for bowel preparation before outpatient colonoscopy
jRCTs041210067Completed
- Sponsor
- Nippon Chemiphar
- Start
- Sep 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised trial in None comparing Elobixibat plus sodium picosulfate with magnesium citrate with Split-dose 2-L PEG with ascorbic acid (2 arms). Primary endpoint: Bowel preparation adequacy (BBPS ≥ 6 with each segment ≥ 2). Started Sep 2021; status: completed.
02
Drugs
elobixibatsodium picosulfatemagnesiummacrogolascorbic acid
Beyond the preview
Go deeper on jRCTs041210067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210067.